| abstract |
The present invention relates to the use of the compounds of formula (I), salts, esters, amides or prodrugs thereof in the treatment of obesity and obesity related diseases. The present invention also relates to novel compounds of formula (I), their preparation and pharmaceutical compositions comprising them.n n n Formula In n n n n n n n Wherein A is an optionally substituted thienyl moiety, Y is O, S or NR 2 , R 1 is branched or unbranched alkyl (with one or more oxygen atoms optionally inserted), alkenyl, alkynyl, Cycloalkyl, cycloalkenyl, aryl, arylalkyl, reduced arylalkyl, arylalkenyl, heteroaryl, heteroarylalkyl, heteroarylalkenyl, reduced aryl, reduced heteroaryl, reduced heteroarylalkyl or any of the above Is a substituted derivative of a group of and R 2 is hydrogen or a group as defined for R 1 . |